IL1B and stroke disorder: Initiation of inflammation after stroke worsens the functional prognosis, while treatments that target inflammatory cytokines, such as TNFα and IL-1, have been shown to be effective (Lambertsen et al., 2019) in restoring neurological outcomes after stroke.